Substrate | Enzyme | Km | Vmax (Actual Rates) | Vmax (Normalized Rates) | Kis | Kinetic Model (r2) |
---|---|---|---|---|---|---|
μM | nmol/min/mg | nmol/min/mg | μM | |||
Psilocin | UGT1A10 | 3851.0 ± 166.6 | 2.53 ± 0.06 | Michaelis-Menten (0.997) | ||
UGT1A9 | Km1 = 1017.0 ± 249.9a | Vmax1 = 0.38 ± 0.14a | Vmax1 = 0.19 ± 0.04a | Two-site biphasic (0.996) | ||
4OH-Indole | UGT1A10 | 3624.0 ± 839.7b | 3.36 ± 0.63b | 2603.0 ± 744.8 | Substrate inhibition (0.992) | |
UGT1A6 | 178.7 ± 14.8 | 9.31 ± 0.45 | 4.78 ± 0.23 | 765.1 ± 65.5 | Substrate inhibition (0.991) | |
UGT2A1 | 3210.0 ± 235.7 | 1.48 ± 0.06 | 0.39 ± 0.02 | Michaelis-Menten (0.992) |
↵a The calculated CLint is 1.69 × 10−4 ± 1.04 × 10−5 ml/min/mg (normalized, 8.29 × 10−5 ± 5.12 × 10−6 ml/min/mg) and represents the linear portion of the biphasic curve (ratio Vmax2/Km2). Data were also fitted to the Michaelis-Menten equation, Km = 12047 ± 1428 μM, Vmax = 3.41 ± 0.31 (normalized, 1.66 ± 0.15) nmol/min/mg, r2 = 0.996.
↵b Data were also fitted to the Hill equation, S50 = 631.6 ± 32.7 μM, Vmax = 1.03 ± 0.02 nmol/min/mg, Hill coefficient h = 1.60 ± 0.11, r2 = 0.986.